RSV Seasonal Vaccine Introduction and Growth Strategy
Currency
2022 currency sales exposure¹
US $
48%
Euro €
17%
Japanese \
7%
Other²
28%
2023 adj. operating profit
US $: 10 cents movement in the average exchange rate for full year
impacts adj. operating profit by approx. +/- 8.0%
Euro €: 10 cents movement in the average exchange rate for full year
impacts adj. operating profit by approx. +/- 0.5%
Japanese \: 10 Yen movement in the average exchange rate for full
year impacts adj. operating profit by approx. +/- 1.0%
2022
2023
Historical average exchange rates quarterly
Q1
Q2
Q3
Q4
Q1
Q2
US $
1.34
1.26
1.18
1.19
1.22
1.25
Euro €
1.19
1.18
1.16
1.15
1.14
1.15
Japanese\
156
162
161
165
162
173
Historical period end exchange rates
US $
Euro €
Japanese \
1.31
1.21
1.11
1.20
1.24
1.26
1.18
1.16
1.13
1.13
1.14
1.17
160
165
160
159
165
183
GSK
1. Based on 2022 GSK continuing operations, including COVID-19 solutions
2. The other currencies that each represent more than 1% of GSK sales include Australian Dollar, Brazilian Real, Canadian Dollar, Chinese Yuan and Indian Rupee. In total, they accounted for 9% of GSK revenues in
2022. If exchange rates were to hold at the closing rates on 30 Jun 2023 ($1.26/£1, €1.17/£1 and Yen 183/£1) for the rest of 2023, the estimated impact on 2023 Sterling turnover growth for GSK would be -2% and if
exchange gains or losses were recognised at the same level as in 2022, the estimated impact on 2023 Sterling Adjusted Operating Profit growth for GSK would be -5%.
55
35View entire presentation